Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue – if the enzymes come in contact with healthy tissue, they could cause issues.
This report contains market size and forecasts of Enzymatic Debridement in global, including the following market information:
Global Enzymatic Debridement Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Enzymatic Debridement Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Enzymatic Debridement companies in 2021 (%)
The global Enzymatic Debridement market was valued at 268.6 million in 2021 and is projected to reach US$ 450.1 million by 2028, at a CAGR of 7.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Collagenase Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Enzymatic Debridement include Smith and Nephew, Stratus Pharma, WeiBang Biopharm, MediWound and Virchow, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enzymatic Debridement manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enzymatic Debridement Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Enzymatic Debridement Market Segment Percentages, by Type, 2021 (%)
Collagenase Product
Papain Product
Others
Global Enzymatic Debridement Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Enzymatic Debridement Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Enzymatic Debridement Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Enzymatic Debridement Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enzymatic Debridement revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Enzymatic Debridement revenues share in global market, 2021 (%)
Key companies Enzymatic Debridement sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Enzymatic Debridement sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Smith and Nephew
Stratus Pharma
WeiBang Biopharm
MediWound
Virchow